Published in J Crohns Colitis on April 14, 2009
Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study. Gut Liver (2014) 1.38
Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease. World J Gastroenterol (2013) 1.28
Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol Hepatol (N Y) (2012) 1.20
Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol (2012) 1.15
Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol (2012) 1.03
The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch (2014) 0.86
Cytomegalovirus Colitis, Cytomegalovirus Hepatitis and Systemic Cytomegalovirus Infection: Common Features and Differences. Inflamm Intest Dis (2016) 0.86
Cytomegalovirus in inflammatory bowel disease: A systematic review. World J Gastroenterol (2016) 0.81
Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-Analysis. Dig Dis Sci (2015) 0.78
Cytomegalovirus infection in patients who required colectomy for toxic megacolon or severe steroid-refractory ulcerative colitis. Dig Dis Sci (2010) 0.77
Assessment of relationship between active ulcerative colitis and cytomegalovirus infection among Iranian patients. Adv Biomed Res (2012) 0.76
The impact of primary and persistent cytomegalovirus infection on the progression of acute colitis in a murine model. Pathophysiology (2014) 0.75
Cytomegalovirus colitis in hospitalized inflammatory bowel disease patients in Taiwan: a referral center study. BMC Gastroenterol (2017) 0.75
Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut (2011) 4.79
Mucosal healing in inflammatory bowel diseases: a systematic review. Gut (2012) 3.02
Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit. Gut (2010) 2.82
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med (2011) 2.74
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol (2010) 1.74
TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology (2006) 1.73
Weight loss at high altitude: pathophysiology and practical implications. Eur J Gastroenterol Hepatol (2006) 1.68
A common CTLA4 haplotype associated with coeliac disease. Eur J Hum Genet (2005) 1.65
Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation. Trials (2007) 1.62
Hypoglycorrhachia in herpes simplex encephalitis. Clin Infect Dis (2004) 1.55
Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med (2005) 1.53
Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun (2007) 1.43
The role of the physician in laboratory medicine: a European perspective. J Clin Pathol (2012) 1.39
Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR. J Clin Microbiol (2004) 1.33
Obstructing giant post-inflammatory polyposis in ulcerative colitis: Case report and review of the literature. J Crohns Colitis (2008) 1.28
Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis. J Histochem Cytochem (2006) 1.17
A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts. Gut (2012) 1.16
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol (2011) 1.16
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety. Am J Gastroenterol (2011) 1.15
The pattern and outcome of acute severe colitis. J Crohns Colitis (2010) 1.06
Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum (2006) 1.01
Medical management of Crohn's disease. BMJ (2008) 0.97
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfus Med Rev (2013) 0.95
Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology (2009) 0.93
Clinical and molecular characteristics of isolated colonic Crohn's disease. Inflamm Bowel Dis (2008) 0.91
Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom. Transfusion (2012) 0.89
Recurrence after abdominal surgery for Crohn's disease: relationship to disease site and surgical procedure. Dis Colon Rectum (2002) 0.89
Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients. Dis Colon Rectum (2005) 0.88
Biosimilars in IBD: hope or expectation? Gut (2013) 0.88
Denonvilliers' fascia lies anterior to the fascia propria and rectal dissection plane in total mesorectal excision. Dis Colon Rectum (2005) 0.88
Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19. J Virol (2006) 0.87
Thiopurine therapy: when to start and when to stop. Eur J Gastroenterol Hepatol (2003) 0.86
Red blood cell transfusion practice in patients presenting with acute upper gastrointestinal bleeding: a survey of 815 UK clinicians. Transfusion (2011) 0.86
What is the optimal treatment for anemia in inflammatory bowel disease? Curr Drug Deliv (2012) 0.85
Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis. Clin Gastroenterol Hepatol (2011) 0.85
Modulation of CD103 expression on human colon carcinoma-specific CTL. J Immunol (2007) 0.85
The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses. J Infect Dis (2013) 0.83
Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease. Scand J Gastroenterol (2009) 0.83
The European consensus on ulcerative colitis: new horizons? Gut (2008) 0.83
A sweet coating--how bacteria deal with sugars. Adv Exp Med Biol (2003) 0.82
Comparison between prospective and retrospective evaluation of Crohn's disease activity index. Am J Gastroenterol (2005) 0.82
The pathology of diverticular disease. Best Pract Res Clin Gastroenterol (2002) 0.81
Therapy of ulcerative colitis: state of the art. Curr Opin Gastroenterol (2008) 0.79
The connective tissue changes of Crohn's disease. Histopathology (2011) 0.79
How to manage the infectious risk under anti-TNF in inflammatory bowel disease. Curr Drug Targets (2010) 0.79
The routine use of histochemical stains in gastrointestinal pathology: a UK-wide survey. Histopathology (2009) 0.78
Conventional drug therapy for inflammatory bowel disease. Scand J Gastroenterol (2015) 0.78
Role of tumor necrosis factor in Crohn's disease. Curr Opin Investig Drugs (2002) 0.77
Recurrent posterior scleritis and orbital myositis as extra-intestinal manifestations of Crohn's disease: Case report and systematic literature review. J Crohns Colitis (2008) 0.77
Mucin expression in the ileoanal reservoir reflects incomplete mucosal adaptation. J Pathol (2002) 0.77
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial. J Crohns Colitis (2008) 0.76
Therapeutic inhibitors of tumor necrosis factor in Crohn's disease. Curr Opin Investig Drugs (2002) 0.76
An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial. J Crohns Colitis (2009) 0.76
Causality and Chance in the Development of Cancer. N Engl J Med (2015) 0.75
Acute upper gastrointestinal bleeding: identifying low risk patients. Gut (2012) 0.75
Endovascular stent-associated infection with Staphylococcus lugdunensis. BMJ Case Rep (2013) 0.75
IBD and IBS: novel mechanisms and future practice. Preface. Dig Dis (2010) 0.75
Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med (2017) 0.75
Use of a monoclonal antibody to sucrase-isomaltase for evaluation of the columnar cuff after stapled restorative proctocolectomy. Dis Colon Rectum (2007) 0.75